Bitcoin is trading at a discount in the US market, with the Coinbase premium showing negative values, indicating weaker US buying pressure. Institutional trading volume on Coinbase Prime declined slightly, and futures data show more short positions than long, suggesting cautious sentiment. Rising US stock market volatility and a stronger dollar are adding to the subdued demand for risk assets like Bitcoin. These combined indicators point to limited buying interest and increased uncertainty among US investors.
Bitcoin’s US market discount and volatility signals offer context for cryptocurrency trends. For readers following crypto markets, here is Pluang's snapshot as of Oct 23, 2026 19:01 WIB: Among 50 major cryptocurrencies priced on Pluang, 26 rose and 23 fell. Notable movers include ATOM at Rp31.893 with a 1-day change of +3.20% and Pluang order activity showing 90% Sell / 10% Buy, FIL at Rp17.709 down 3.03% with 24% Sell / 76% Buy activity, and SAND at Rp949 down 2.93% with 28% Sell / 72% Buy activity. Typical hold times range from 61 to 124 days across these assets.
Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...
ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...
Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...
eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...
Balchem Corporation reported strong Q3 2026 results with net sales of $290.7 million, up 8.6% year-over-year, and net earnings of $46.7 million, a 16% increase. Growth was driven by all three segments: Human Nutrition and Health, Animal Nutrition and...
